Codexis, Inc. (CDXS)
NASDAQ: CDXS · IEX Real-Time Price · USD
3.550
+0.250 (7.58%)
At close: Jul 19, 2024, 4:00 PM
3.670
+0.120 (3.38%)
Pre-market: Jul 22, 2024, 7:32 AM EDT

Codexis Revenue

Codexis had revenue of $74.23M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $17.07M with 31.51% year-over-year growth. In the year 2023, Codexis had annual revenue of $70.14M.

Revenue (ttm)
$74.23M
Revenue Growth
-36.13%
P/S Ratio
3.37
Revenue / Employee
$426,632
Employees
174
Market Cap
250.48M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202370.14M-68.45M-49.39%
Dec 31, 2022138.59M33.84M32.30%
Dec 31, 2021104.75M35.70M51.69%
Dec 31, 202069.06M598.00K0.87%
Dec 31, 201968.46M7.86M12.98%
Dec 31, 201860.59M10.57M21.13%
Dec 31, 201750.02M1.19M2.43%
Dec 31, 201648.84M7.03M16.82%
Dec 31, 201541.80M6.50M18.40%
Dec 31, 201435.31M3.39M10.60%
Dec 31, 201331.92M-56.38M-63.85%
Dec 31, 201288.30M-35.57M-28.71%
Dec 31, 2011123.87M16.76M15.65%
Dec 31, 2010107.10M24.20M29.18%
Dec 31, 200982.91M32.43M64.25%
Dec 31, 200850.48M25.15M99.26%
Dec 31, 200725.33M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AirSculpt Technologies 197.72M
Nektar Therapeutics 90.17M
AVITA Medical 51.50M
Nanobiotix 40.23M
Zevra Therapeutics 28.01M
Senseonics Holdings 23.30M
Profound Medical 5.33M
Atai Life Sciences 277.00K
Revenue Rankings